180 related articles for article (PubMed ID: 19948041)
1. Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.
Liu P; Xie BL; Cai SH; He YW; Zhang G; Yi YM; Du J
BMC Cancer; 2009 Nov; 9():416. PubMed ID: 19948041
[TBL] [Abstract][Full Text] [Related]
2. Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells.
He YW; Wang HS; Zeng J; Fang X; Chen HY; Du J; Yang XY
Life Sci; 2013 Oct; 93(15):509-15. PubMed ID: 23942267
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
[TBL] [Abstract][Full Text] [Related]
4. [Sodium butyrate down-regulates IFN-γ-induced indoleamine 2, 3 dioxygenase and promotes its acetylation and ubiquitination in CNE2 nasopharyngeal carcinoma cells].
Wang X; Zhang Q; Qiu Y; Xie W; Zhang K; Jiang G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):487-90. PubMed ID: 25854569
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
Tanizaki Y; Kobayashi A; Toujima S; Shiro M; Mizoguchi M; Mabuchi Y; Yagi S; Minami S; Takikawa O; Ino K
Cancer Sci; 2014 Aug; 105(8):966-73. PubMed ID: 24826982
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
[TBL] [Abstract][Full Text] [Related]
8. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.
Zhang G; Liu WL; Zhang L; Wang JY; Kuang MH; Liu P; Lin YH; Dai SQ; Du J
Clin Dev Immunol; 2011; 2011():384726. PubMed ID: 22013481
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation.
Jiang GM; Wang HS; Du J; Ma WF; Wang H; Qiu Y; Zhang QG; Xu W; Liu HF; Liang JP
Cancer Immunol Res; 2017 Jan; 5(1):42-51. PubMed ID: 27923823
[TBL] [Abstract][Full Text] [Related]
10. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
12. Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition.
Zhu L; Ji F; Wang Y; Zhang Y; Liu Q; Zhang JZ; Matsushima K; Cao Q; Zhang Y
J Immunol; 2006 Dec; 177(11):8226-33. PubMed ID: 17114500
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis.
Ohtaki H; Ito H; Ando K; Ishikawa T; Hoshi M; Ando T; Takamatsu M; Hara A; Moriwaki H; Saito K; Seishima M
Biochim Biophys Acta; 2014 Sep; 1842(9):1464-71. PubMed ID: 24768802
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells.
Kai S; Goto S; Tahara K; Sasaki A; Tone S; Kitano S
Scand J Immunol; 2004 Feb; 59(2):177-82. PubMed ID: 14871294
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
Ou X; Cai S; Liu P; Zeng J; He Y; Wu X; Du J
J Cancer Res Clin Oncol; 2008 May; 134(5):525-33. PubMed ID: 17909857
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
Li Q; Harden JL; Anderson CD; Egilmez NK
J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
[TBL] [Abstract][Full Text] [Related]
17. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.
Godin-Ethier J; Hanafi LA; Duvignaud JB; Leclerc D; Lapointe R
Mol Immunol; 2011 Oct; 49(1-2):253-9. PubMed ID: 21937116
[TBL] [Abstract][Full Text] [Related]
18. Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity.
Gu T; Rowswell-Turner RB; Kilinc MO; Egilmez NK
Cancer Res; 2010 Jan; 70(1):129-38. PubMed ID: 20028855
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.
Jeong YI; Kim SW; Jung ID; Lee JS; Chang JH; Lee CM; Chun SH; Yoon MS; Kim GT; Ryu SW; Kim JS; Shin YK; Lee WS; Shin HK; Lee JD; Park YM
J Biol Chem; 2009 Feb; 284(6):3700-8. PubMed ID: 19075017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
